Funding for this research was provided by:
Innovative Medicines Initiative (IMI) 2 Joint Undertaking with H2020 (115902)
Received: 7 April 2021
Accepted: 22 September 2021
First Online: 13 October 2021
: This study was conducted in accordance with the Declaration of Helsinki and received a favourable review from the University of Nottingham Research Ethics Committee (ref 277-1802) and from the Health Research Authority (Ref 19/HRA/5041). Respondents provided informed consent to take part in the study by reading the information provided on the first page of the study and indicating consent using the questions listed on the first page of the online questionnaire.
: Survey respondents remained anonymous and as such this section is not applicable.
: There are no competing interests to declare.